Episodic withdrawal promotes psychomotor sensitization to morphine.
The relative intermittency or continuity of drug delivery is a major determinant of addictive liability, and also influences the impact of drug exposure on brain function and behavior. Events that occur during the offset of drug action (ie, acute withdrawal) may have an important role in the consequences of intermittent drug exposure. We assessed whether recurrent episodes of acute withdrawal contribute to the development of psychomotor sensitization in rodents during daily morphine exposure. The acoustic startle reflex--a measure of anxiety induced by opiate withdrawal-was used to resolve and quantify discrete withdrawal episodes, and pharmacological interventions were used to manipulate withdrawal severity. Startle potentiation was observed during spontaneous withdrawal from a single morphine exposure, and individual differences in initial withdrawal severity positively predicted the subsequent development of sensitization. Manipulations that reduce or exacerbate withdrawal severity also produced parallel changes in the degree of sensitization. These results demonstrate that the episodic experience of withdrawal during daily drug exposure has a novel role in promoting the development of psychomotor sensitization--a prominent model of drug-induced neurobehavioral plasticity. Episodic withdrawal may have a pervasive role in many effects of intermittent drug exposure and contribute to the development of addiction.
Rothwell
Patrick E
PE
Graduate Program in Neuroscience and Departments of Neuroscience and Psychology, University of Minnesota, Minneapolis, MN, USA.
Gewirtz
Jonathan C
JC
Thomas
Mark J
MJ
D000161:Acoustic Stimulation / Q000379:methods; D000818:Animals; D004347:Drug Interactions; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013216:Reflex, Startle / Q000187:drug effects*; D013997:Time Factors
D009270:Naloxone; D009020:Morphine
J Pharmacol Exp Ther. 2003 Feb;304(2):603-9
12538812
Psychopharmacology (Berl). 2002 Nov;164(3):318-28
12424556
Neuron. 1997 Sep;19(3):591-611
9331351
Am J Psychiatry. 2007 Aug;164(8):1149-59
17671276
Annu Rev Psychol. 2003;54:25-53
12185211
Behav Brain Res. 1997 Mar;84(1-2):225-39
9079787
Neuropharmacology. 2004;47 Suppl 1:167-79
15464135
Neuropsychopharmacology. 2009 Sep;34(10):2285-95
19494807
Neuropsychopharmacology. 2004 Jul;29(7):1312-20
15039768
Synapse. 1993 Jul;14(3):243-5
8211708
J Pharmacol Exp Ther. 1975 Dec;195(3):499-504
1195133
Brain Res. 2010 Feb 16;1314:139-44
19891960
Pain. 1997 Apr;70(2-3):125-32
9150285
Psychopharmacology (Berl). 2005 Apr;178(4):367-80
15765253
Brain Res. 2000 Sep 29;878(1-2):20-31
10996133
Brain Res. 1986 Jun;396(2):157-98
3527341
Trends Pharmacol Sci. 2005 Feb;26(2):82-7
15681025
Arch Intern Med. 1966 Oct;118(4):304-9
4162686
Pharmacol Biochem Behav. 2007 May;87(1):171-8
17524462
J Neurosci. 2001 Jun 1;21(11):4074-80
11356895
J Neurosci. 2004 Oct 20;24(42):9414-24
15496677
Neuropsychopharmacology. 2005 Sep;30(9):1662-9
15726114
Addict Behav. 2003 Jun;28(4):817-21
12726795
Pharmacol Biochem Behav. 1992 Sep;43(1):243-8
1409810
J Consult Clin Psychol. 1993 Oct;61(5):743-50
8245272
Trends Neurosci. 2002 Dec;25(12):610-5
12446127
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):334-44
19150477
Psychopharmacology (Berl). 1988;96(1):110-5
3147470
Neuropsychopharmacology. 2002 Jan;26(1):18-26
11751029
Psychopharmacology (Berl). 2003 Jul;168(3):280-92
12712232
Annu Rev Neurosci. 2006;29:565-98
16776597
Psychopharmacology (Berl). 2005 Apr;178(4):353-66
15696323
Am J Psychiatry. 1999 Sep;156(9):1444-6
10484960
Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
1665095
J Neurosci. 2003 Sep 10;23(23):8360-9
12967998
J Neurosci. 1997 Aug 15;17(16):6434-46
9236251
Neuropsychopharmacology. 2010 Jan;35(1):217-38
19710631
Psychopharmacology (Berl). 2008 Mar;196(4):649-60
18026718
Life Sci. 1982 Oct 11;31(15):1531-40
6890614
J Neurosci. 1996 Mar 1;16(5):1957-63
8774462
Neuropsychopharmacology. 2007 Nov;32(11):2290-300
17314916
Neuroscience. 1997 Jan;76(1):167-76
8971769
J Pharmacol Exp Ther. 1977 Apr;201(1):44-54
557543
Science. 1981 May 22;212(4497):943-5
7195068
J Neurosci. 2005 Jun 1;25(22):5389-96
15930388
Neuropsychopharmacology. 2010 Jan;35(1):105-35
19693004
Neuropsychopharmacology. 2004 Sep;29(9):1664-74
15138436
Neuropharmacology. 1978 Dec;17(12):1081-4
570650
Neurosci Biobehav Rev. 2004 Jan;27(8):827-39
15019432
Brain Res. 1993 Oct 1;623(2):341-4
8221119
Psychol Rev. 2004 Jan;111(1):33-51
14756584
Behav Neurosci. 1995 Feb;109(1):91-105
7734084
Behav Brain Res. 2008 Jun 26;190(1):119-23
18378328
Neuropsychopharmacology. 2003 Nov;28(11):1960-72
12915862
J Pharmacol Exp Ther. 1987 Apr;241(1):204-12
3572784
J Abnorm Psychol. 2005 May;114(2):223-34
15869353
Psychopharmacology (Berl). 2004 Jan;171(2):140-7
13680079
Behav Pharmacol. 1993;4(4):289-312
11224198
J Pharmacol Exp Ther. 1995 May;273(2):808-15
7752084
Neuropsychopharmacology. 2008 Jan;33(1):166-80
17805308
J Neurosci. 2001 Sep 15;21(18):7397-403
11549750
Eur J Pharmacol. 1996 Mar 28;299(1-3):33-9
8901005
J Neurosci. 1996 Jan;16(1):274-82
8613793
J Pharmacol Exp Ther. 1987 Oct;243(1):281-7
3668859
Psychopharmacology (Berl). 2004 Oct;175(4):428-35
15175841
Behav Brain Res. 2007 Dec 11;185(1):49-58
17692933
Br J Pharmacol. 1972 Oct;46(2):213-24
4651770
Psychopharmacology (Berl). 2000 Apr;149(2):115-20
10805605
Pharmacol Biochem Behav. 1998 Nov;61(3):331-3
9768568
Neuropsychopharmacology. 1998 Mar;18(3):222-32
9471119
Life Sci. 1980 Apr 21;26(16):1275-82
6991841
Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
10972458
Nat Neurosci. 2007 Jan;10(1):93-9
17143271
Sci Am. 1982 Mar;246(3):128-41
7043731
Science. 2009 Jul 10;325(5937):207-10
19590003
Neuroscience. 2007 Nov 30;150(1):8-13
17961928
Alcohol. 2000 Aug;22(1):19-24
11109024
Neuropharmacology. 2008 Mar;54(3):475-86
18082850
Psychopharmacology (Berl). 1997 May;131(2):115-22
9201798
Psychopharmacology (Berl). 2008 Apr;197(2):203-16
18097654
Brain Res. 1991 Aug 30;558(1):163-5
1933379
Nat Rev Neurosci. 2007 Nov;8(11):844-58
17948030
Eur J Neurosci. 1998 Nov;10(11):3565-71
9824469
Mol Psychiatry. 2004 Jun;9(6):557-69
15098002
Psychopharmacology (Berl). 2009 Nov;207(1):13-25
19669732
Eur J Neurosci. 1998 Feb;10(2):782-5
9749743
J Neurochem. 2005 Feb;92(3):536-45
15659224
J Neurosci. 2006 Aug 16;26(33):8549-58
16914681
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
8401595
Psychopharmacology (Berl). 2001 Jun;156(1):98-107
11465640
Psychopharmacology (Berl). 1993;112(4):511-7
7871065
Pharmacol Biochem Behav. 2004 Dec;79(4):661-9
15582674
Psychopharmacology (Berl). 2004 Feb;171(4):398-404
13680070
Neurosci Biobehav Rev. 2004 Jan;27(8):739-49
15019424